Respiratory Distress Syndrome, Acute
6
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
Establishment and Evaluation of Prenatal Prevention and Treatment Strategy for NARDS
Multimodal Database and Large Language Model for ARDS
Implementation of Lung Protective Ventilation in Patients With Acute Respiratory Failure
Bioelectrical Impedance in Monitoring Hyperhydration and Polyneuromyopathy in Critically Ill Patients
Extended Prone Position Duration COVID-19-related ARDS: a Retrospective Study